Randomized trials in oncology: a fertile ground for controversy

The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided care.

Cell reports. Medicine·2026

Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration.

JCO precision oncology·2026

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.

Gynecologic oncology·2022

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery.

Gynecologic oncology reports·2020

The Evolving Arena of Ovarian Cancer Maintenance Therapy.

Oncology·2019

Pharmaceutical Management of Ovarian Cancer: Current Status.

Drugs·2019

Percutaneous Management of Desmoid Tumors.

Current oncology reports·2026

Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.

Current oncology reports·2026

The Role of Omega-3 Polyunsaturated Fatty Acids in Modulating Inflammation and Breast Cancer: A Systematic Review of In Vitro, Animal, and Human Studies.

Current oncology reports·2026

Periodontitis as a Modulator of Malignant Transformation in Oral Potentially Malignant Disorders: A Narrative Review of Biological Mechanisms and Clinical Implications.

Current oncology reports·2026

Early-Onset Colorectal Cancer: From Epidemiologic Shift to Life-Course Carcinogenesis and Age-Attuned Care.

Current oncology reports·2026

Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies.

Current oncology reports·2026

Paulownin: a promising agent In the fight against the invasion and immune escape in triple-negative breast cancer.

Immunopharmacology and immunotoxicology·2026

Tumor-host metabolic interactions in the microenvironment and macroenvironment: Mechanisms and targeting strategies.

Chinese medical journal·2026

Integrative transcriptomic and single-cell analysis identifies anoikis-related molecular signatures in vascular calcification.

Renal failure·2026

Recent Advances (2020-2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies-A Comprehensive Review.

Cancer management and research·2026

Editorial: Cancer cell metabolism and tumor microenvironment remodel.

Frontiers in genetics·2026

Prevention of Venous Thromboembolism in Patients with Ovarian Cancer: The State of the Research.

International journal of women's health·2026

Related Experiment Videos

Randomized trials in oncology: a fertile ground for controversy

Related Concept Videos

The IMMUNO-BIOMAP trial in NSCLC: An adaptive multimodal framework for biomarker-guided care.

Use of ALK Inhibitors in Patients With Nonlung Malignancies Bearing ALK Alteration Prolongs Treatment Duration.

What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (≥10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer.

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery.

The Evolving Arena of Ovarian Cancer Maintenance Therapy.

Pharmaceutical Management of Ovarian Cancer: Current Status.

Percutaneous Management of Desmoid Tumors.

Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.

The Role of Omega-3 Polyunsaturated Fatty Acids in Modulating Inflammation and Breast Cancer: A Systematic Review of In Vitro, Animal, and Human Studies.

Periodontitis as a Modulator of Malignant Transformation in Oral Potentially Malignant Disorders: A Narrative Review of Biological Mechanisms and Clinical Implications.

Early-Onset Colorectal Cancer: From Epidemiologic Shift to Life-Course Carcinogenesis and Age-Attuned Care.

Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma: from Tumor Biology to Biomarker-Guided Strategies.

Paulownin: a promising agent In the fight against the invasion and immune escape in triple-negative breast cancer.

Tumor-host metabolic interactions in the microenvironment and macroenvironment: Mechanisms and targeting strategies.

Integrative transcriptomic and single-cell analysis identifies anoikis-related molecular signatures in vascular calcification.

Recent Advances (2020-2025) in Estrogen and ER-Positive Breast Cancer: Receptor Signaling, Tumor Microenvironment, Endocrine Therapy Resistance and Innovative Treatment Strategies-A Comprehensive Review.

Editorial: Cancer cell metabolism and tumor microenvironment remodel.

Prevention of Venous Thromboembolism in Patients with Ovarian Cancer: The State of the Research.

Related Experiment Videos

Randomized trials in oncology: a fertile ground for controversy

Related Concept Videos

Related Articles